-
公开(公告)号:US20240363253A1
公开(公告)日:2024-10-31
申请号:US18630289
申请日:2024-04-09
发明人: Alex Stenzler , Mac Liaw , Martin Stegenga , Michael Taylor
IPC分类号: G16H50/30 , A61B5/00 , A61B5/0205 , A61B5/021 , A61B5/087 , A61B5/1455 , G16H10/20 , G16H10/60 , G16H20/10 , G16H80/00
CPC分类号: G16H50/30 , A61B5/0022 , A61B5/0205 , A61B5/744 , A61B5/746 , G16H10/20 , G16H10/60 , G16H20/10 , G16H80/00 , A61B5/021 , A61B5/0871 , A61B5/14551
摘要: A method for treating a patient with respiratory illness is described according to one embodiment. The method includes the steps of receiving a set of screening spirometry test data measured by a spirometer, generating a first patient performance score based on the received set of screening spirometry test data, generating one of a first high alert when the first patient performance score crosses a first threshold and a first low alert when the first patient performance score fails to cross the first threshold, receiving a set of at-home physiological test data, generating a second patient performance score based on the received set of at-home physiological test data, generating one of a second high alert when the second patient performance score crosses a second threshold and a second low alert when the second patient performance score fails to cross the second threshold, receiving a set of at-home patient survey data entered by the patient, generating a third patient performance score based on the received set of at-home patient survey data, and generating one of a third high alert when the third patient performance score crosses a third threshold and a third low alert when the third patient performance score fails to cross the third threshold.
-
公开(公告)号:US20240358933A1
公开(公告)日:2024-10-31
申请号:US18768112
申请日:2024-07-10
发明人: Christian Rehbein , Sven Hagebusch , Chris Knorr , Maurice Toporek , Matthias Felber , Alexander Heinrich
CPC分类号: A61M5/3155 , A61M5/20 , A61M5/31585 , G16H20/10 , A61M2005/3126 , A61M2205/3306 , A61M2205/3313 , A61M2205/3317 , A61M2205/3327 , A61M2205/3561 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/587
摘要: A data collection device including an attachment assembly for attaching the data collection device to a dose setting dial of a medicament administration device, a light source configured to illuminate a portion of a surface of an internal component of the medicament administration device including a pattern of relatively reflective and non-reflecting regions formed on the surface of the internal component, and an optical sensor configured to receive light reflected by at least the relatively reflective regions.
-
3.
公开(公告)号:US20240355443A1
公开(公告)日:2024-10-24
申请号:US18602287
申请日:2024-03-12
发明人: Tungadri BOSE , Harrisham KAUR , Rashmi SINGH , Anirban DUTTA , Mohammed Monzoorul HAQUE , Sharmila Shekhar MANDE
摘要: The present disclosure is related to a method and system for stratification of subjects as one of responders or non-responders to a therapy. It is imperative to critically evaluate the baseline/initial microbiome structure and composition of individuals and stratifying them before prescribing any microbiome-based drug/dietary interventions. The method identifies a panel of biological features/indicators/markers/signatures that can accurately stratify/classify/group individuals into responders and non-responders (for a given microbiome-based drug/therapy) based upon the differences in the metabolic functions of the gut microbial communities between the baseline gut microbiome profile (i.e. before the administration of an intervention) and after treatment gut microbiome profile (i.e. after the administration of the intervention). Individuals with samples showing an improvement in gut-health status after the administration of the pre-biotic intervention were tagged as responders and the rest were tagged as non-responders.
-
公开(公告)号:US20240355441A1
公开(公告)日:2024-10-24
申请号:US18137692
申请日:2023-04-21
申请人: Phil Baker
发明人: Phil Baker
CPC分类号: G16H20/10 , G16H10/60 , A61J7/0076
摘要: A system for redistributing medication including a computing device configured to receive a communication regarding a medication donation from a donor, wherein the communication includes donor medication information regarding the medication donation. The computing device further configured to verify the medication donation including verifying the identity of the donated medication. Verifying the identity of the donated medication includes collecting actual medication information. The computing device also configured to enter final medication information corresponding to the medication donation into the medication database. The computing device configured to match the donated medication to a recipient selected from a recipient database as a function of a set of associated recipient data.
-
公开(公告)号:US12124973B1
公开(公告)日:2024-10-22
申请号:US16583827
申请日:2019-09-26
申请人: WALGREEN CO.
发明人: Youbei Lou , Erik Groves , Evie Makris , Alexandra Broadus
摘要: Systems and methods for using predictive modeling to improve patient adherence to prescription medication regimens are provided. Training data may be generated using historical prescription adherence data associated with a patient population. A prescription adherence machine learning model may be trained using the training data, and the trained model may be applied to current prescription adherence data associated with a patient to predict a likelihood that a proportion of days that the patient will be covered by a prescribed medication will be below a threshold value over a calendar year. A patient risk score may be generated for the patient based at least in part on the predicted likelihood that the proportion of days covered by the prescribed medication will be below the threshold value. Based on the patient's patient risk score, the patient may be automatically contacted for intervention.
-
公开(公告)号:US20240342405A1
公开(公告)日:2024-10-17
申请号:US18753326
申请日:2024-06-25
IPC分类号: A61M15/00 , A61B5/00 , A61B5/08 , A61K31/138 , A61M11/00 , C07K16/24 , C07K16/28 , C07K16/42 , G16H20/10 , G16H20/13 , G16H50/30 , G16H50/70
CPC分类号: A61M15/009 , A61B5/0826 , A61B5/4848 , A61B5/7275 , A61K31/138 , A61M15/0001 , A61M15/0025 , A61M15/003 , A61M15/008 , A61M15/0091 , C07K16/244 , C07K16/247 , C07K16/2866 , C07K16/4291 , G16H20/10 , G16H20/13 , G16H50/30 , G16H50/70 , A61M11/00 , A61M15/0026 , A61M2202/064 , A61M2205/05 , A61M2205/18 , A61M2205/3327 , A61M2205/3331 , A61M2205/3358 , A61M2205/3584 , A61M2205/502 , A61M2205/505 , A61M2205/52 , A61M2230/30 , A61M2230/40 , C07K2317/21 , C07K2317/24 , C07K2317/52
摘要: Provided is a system for determining a probability of a respiratory disease exacerbation in a subject. The system comprises an inhaler arrangement for delivering a medicament to the subject. The medicament may be a rescue medicament and/or a maintenance medicament. The inhaler arrangement has a use-detection system configured to determine an inhalation performed by the subject using the inhaler arrangement. A sensor system is configured to measure a parameter relating to airflow during the inhalation. A user interface enables user-input of an indication of a status of the respiratory disease being experienced by the subject. A processor is configured to determine the probability of the respiratory disease exacerbation based on the recorded inhalation(s) from the use-detection system, the parameter(s) received from the sensor system, and the indication received from the user interface. Further provided is a method for determining the probability of a respiratory disease exacerbation in a subject.
-
公开(公告)号:US12119098B2
公开(公告)日:2024-10-15
申请号:US18295279
申请日:2023-04-04
申请人: Milo Health, Inc.
发明人: Robert Max Siegel
IPC分类号: G06Q30/00 , G06Q30/0283 , G06Q30/0601 , G16H20/10 , G16H40/63
CPC分类号: G16H20/10 , G06Q30/0283 , G06Q30/0613 , G06Q30/0639 , G16H40/63
摘要: Systems and methods are disclosed for interacting with a prescription submission system, a cloud computing system, and a prescription processing system to transmit prescriptions to an optimal pharmacy based on user information. User information, a location, and a prescription including a treatment e.g., medicine) may be received from a user or a health care professional. A plurality of pharmacies may be identified based at least on availability of the treatment, each of the plurality of pharmacies meeting a location criterion based on the location. Treatment pricing may be identified for each of the identified plurality of pharmacies. The plurality of pharmacies and the corresponding pricing information may be transmitted to a computing device. A selected pharmacy from the plurality of pharmacies may be received, from the computing device, and, the prescription may be transmitted to be received at the selected pharmacy's prescription processing system.
-
公开(公告)号:US12119092B2
公开(公告)日:2024-10-15
申请号:US16451349
申请日:2019-06-25
摘要: When a patient is referred to a physician or hospital for a multi-encounter medical procedure, a computer retrieves information from a patient's electronic medical record (EMR) stored in an electronic medical record system of a medical facility. If the EMR suggests that the patient is possibly at risk, a computer poses a questionnaire to the patient, the questionnaire being specifically diagnostic for the suggested risk condition and/or appropriateness of care preferences of the patient. A computer evaluates the EMR information and questionnaire answers together to evaluate risk characteristics of the patient. Based on the evaluating, the computer recommends at least one pathway to be implemented by the medical staff in the patient's care.
-
公开(公告)号:US12114998B2
公开(公告)日:2024-10-15
申请号:US17221107
申请日:2021-04-02
IPC分类号: A61B5/00 , A61B5/0205 , A61B5/11 , A61B5/145 , A61M5/172 , A61M5/20 , A61M15/00 , A61M15/08 , G16H10/60 , G16H20/10 , G16H20/30 , G16H20/40 , G16H20/60 , G16H40/20 , G16H40/40 , G16H40/67 , G16H50/30 , G16H70/40 , H04W12/02 , H04W12/0431 , A61B5/021 , A61B5/024
CPC分类号: A61B5/4839 , A61B5/0022 , A61B5/02055 , A61B5/1101 , A61B5/1112 , A61B5/1118 , A61B5/14532 , A61B5/14542 , A61B5/4266 , A61B5/4866 , A61M5/1723 , A61M5/2033 , A61M15/0065 , A61M15/08 , G16H10/60 , G16H20/10 , G16H20/30 , G16H20/40 , G16H20/60 , G16H40/20 , G16H40/40 , G16H40/67 , G16H50/30 , G16H70/40 , H04W12/02 , H04W12/0431 , A61B5/021 , A61B5/024 , A61B2560/0242 , A61M2205/3317 , A61M2205/3327 , A61M2205/3553 , A61M2205/3584 , A61M2205/50 , A61M2205/502 , A61M2205/505 , A61M2205/52 , A61M2230/04 , A61M2230/20 , A61M2230/201 , A61M2230/50 , A61M2230/63
摘要: In general, systems and methods for monitoring and communicating information using drug administration devices are provided.
-
公开(公告)号:US20240339183A1
公开(公告)日:2024-10-10
申请号:US18649486
申请日:2024-04-29
申请人: ProSciento, Inc.
发明人: Marcus Hompesch , Maria Nunez , Helge Guenther , Will Santos , Zoe Molina , Brian Mooney
摘要: A patient portal system may include a patient database module configured to interpret a patient profile value, a clinical database module configured to interpret a clinical study description, and a patient interface module configured to implement a patient clinical study interface in response to the patient profile value and the clinical study description.
-
-
-
-
-
-
-
-
-